Hutchmed Limited Stock Analysis
| HMDCF Stock | USD 3.02 0.00 0.00% |
HUTCHMED (China)'s financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. HUTCHMED (China)'s financial risk is the risk to HUTCHMED (China) stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that HUTCHMED (China)'s debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which HUTCHMED (China) is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of HUTCHMED (China) to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, HUTCHMED (China) is said to be less leveraged. If creditors hold a majority of HUTCHMED (China)'s assets, the Company is said to be highly leveraged.
HUTCHMED Limited is overvalued with Real Value of 2.67 and Hype Value of 3.02. The main objective of HUTCHMED (China) pink sheet analysis is to determine its intrinsic value, which is an estimate of what HUTCHMED Limited is worth, separate from its market price. There are two main types of HUTCHMED (China)'s stock analysis: fundamental analysis and technical analysis.
The HUTCHMED (China) pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and HUTCHMED (China)'s ongoing operational relationships across important fundamental and technical indicators.
HUTCHMED |
HUTCHMED Pink Sheet Analysis Notes
About 45.0% of the company shares are held by company insiders. The book value of HUTCHMED (China) was currently reported as 0.95. The company had not issued any dividends in recent years. HUTCHMED Limited had 10:1 split on the 30th of May 2019. HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. The company was incorporated in 2000 and is headquartered in Central, Hong Kong. Hutchison China operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2110 people.The quote for HUTCHMED Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about HUTCHMED Limited call Weiguo BSc at 852 2128 1188 or check out https://www.hutch-med.com.HUTCHMED Limited Investment Alerts
| HUTCHMED Limited generated a negative expected return over the last 90 days | |
| HUTCHMED Limited has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 356.13 M. Net Loss for the year was (194.65 M) with loss before overhead, payroll, taxes, and interest of (201.19 M). | |
| HUTCHMED Limited has accumulated about 829.71 M in cash with (204.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.98. | |
| Roughly 45.0% of the company shares are held by company insiders |
HUTCHMED Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HUTCHMED (China)'s market, we take the total number of its shares issued and multiply it by HUTCHMED (China)'s current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.HUTCHMED Profitablity
The company has Profit Margin (PM) of (0.64) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.95) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.95.Technical Drivers
As of the 8th of February, HUTCHMED (China) retains the risk adjusted performance of (0.13), and Market Risk Adjusted Performance of 1.14. HUTCHMED (China) technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out HUTCHMED Limited coefficient of variation, as well as the relationship between the total risk alpha and skewness to decide if HUTCHMED (China) is priced adequately, providing market reflects its last-minute price of 3.02 per share. Given that HUTCHMED Limited has variance of 2.9, we strongly advise you to confirm HUTCHMED Limited's regular market performance to make sure the company can sustain itself next year.HUTCHMED Limited Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in HUTCHMED (China) price series with the more recent values given greater weights.
HUTCHMED (China) Predictive Daily Indicators
HUTCHMED (China) intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of HUTCHMED (China) pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
HUTCHMED (China) Forecast Models
HUTCHMED (China)'s time-series forecasting models are one of many HUTCHMED (China)'s pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary HUTCHMED (China)'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.HUTCHMED Limited Debt to Cash Allocation
Many companies such as HUTCHMED (China), eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
The company has a current ratio of 3.12, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist HUTCHMED (China) until it has trouble settling it off, either with new capital or with free cash flow. So, HUTCHMED (China)'s shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HUTCHMED Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HUTCHMED to invest in growth at high rates of return. When we think about HUTCHMED (China)'s use of debt, we should always consider it together with cash and equity.HUTCHMED (China) Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the HUTCHMED (China)'s operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of HUTCHMED (China), which in turn will lower the firm's financial flexibility.About HUTCHMED Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how HUTCHMED (China) prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling HUTCHMED shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as HUTCHMED (China). By using and applying HUTCHMED Pink Sheet analysis, traders can create a robust methodology for identifying HUTCHMED entry and exit points for their positions.
HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. The company was incorporated in 2000 and is headquartered in Central, Hong Kong. Hutchison China operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2110 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding HUTCHMED (China) to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Complementary Tools for HUTCHMED Pink Sheet analysis
When running HUTCHMED (China)'s price analysis, check to measure HUTCHMED (China)'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HUTCHMED (China) is operating at the current time. Most of HUTCHMED (China)'s value examination focuses on studying past and present price action to predict the probability of HUTCHMED (China)'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HUTCHMED (China)'s price. Additionally, you may evaluate how the addition of HUTCHMED (China) to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |